TY - JOUR
T1 - Predictors of Adverse Pregnancy Outcomes in Pregnant Women Living with Obesity
T2 - A Systematic Review
AU - Fakhraei, Romina
AU - Denize, Kathryn
AU - Simon, Alexandre
AU - Sharif, Ayni
AU - Zhu-Pawlowsky, Julia
AU - Dingwall-Harvey, Alysha L.J.
AU - Hutton, Brian
AU - Pratt, Misty
AU - Skidmore, Becky
AU - Ahmadzai, Nadera
AU - Heslehurst, Nicola
AU - Hayes, Louise
AU - Flynn, Angela C.
AU - Velez, Maria P.
AU - Smith, Graeme
AU - Lanes, Andrea
AU - Rybak, Natalie
AU - Walker, Mark
AU - Gaudet, Laura
N1 - Funding Information:
Funding: This study was funded by the Canadian Institutes of Health Research (CIHR) agency (Grant #MFM-146444).
Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2022/2/1
Y1 - 2022/2/1
N2 - Obesity is a well-recognized risk factor for pregnancy complications. Most studies to date are in large cohorts, with results presented in a way that assumes all women living with obesity are at equal risk. This study investigates which women living with obesity are at higher risk of specific pregnancy complications. A systematic search of MEDLINE and Embase identified 7894 prospective or retrospective cohort studies exploring predictors of adverse outcomes among pregnant women living with obesity. Following screening, 61 studies were deemed eligible. Studies were selected if the effects of exposure to any predictor amongst pregnant women living with obesity could be collected. Maternal characteristics assessed for association with adverse outcomes included maternal age, race/ethnicity, maternal height, mode of conception, complement activation factors, and history of various comorbidities/procedures. Gestational diabetes mellitus was the most studied outcome (n = 32), followed by preterm birth (n = 29), preeclampsia (n = 27), low birthweight infants (n = 20), small for gestational age newborns (n = 12), and stillbirth (n = 7). This review identified important characteristics that should be considered during the screening and follow-up sessions of pregnant women living with obesity, including pre-existing type 1 diabetes, maternal age <20 years or ≥35 years, non-White ethnicity, abdominal adiposity obesity, and history of bariatric surgery.
AB - Obesity is a well-recognized risk factor for pregnancy complications. Most studies to date are in large cohorts, with results presented in a way that assumes all women living with obesity are at equal risk. This study investigates which women living with obesity are at higher risk of specific pregnancy complications. A systematic search of MEDLINE and Embase identified 7894 prospective or retrospective cohort studies exploring predictors of adverse outcomes among pregnant women living with obesity. Following screening, 61 studies were deemed eligible. Studies were selected if the effects of exposure to any predictor amongst pregnant women living with obesity could be collected. Maternal characteristics assessed for association with adverse outcomes included maternal age, race/ethnicity, maternal height, mode of conception, complement activation factors, and history of various comorbidities/procedures. Gestational diabetes mellitus was the most studied outcome (n = 32), followed by preterm birth (n = 29), preeclampsia (n = 27), low birthweight infants (n = 20), small for gestational age newborns (n = 12), and stillbirth (n = 7). This review identified important characteristics that should be considered during the screening and follow-up sessions of pregnant women living with obesity, including pre-existing type 1 diabetes, maternal age <20 years or ≥35 years, non-White ethnicity, abdominal adiposity obesity, and history of bariatric surgery.
KW - Adverse outcomes
KW - Obesity
KW - Predictors
KW - Pregnancy
UR - http://www.scopus.com/inward/record.url?scp=85124344868&partnerID=8YFLogxK
U2 - 10.3390/ijerph19042063
DO - 10.3390/ijerph19042063
M3 - Article
AN - SCOPUS:85124344868
SN - 1661-7827
VL - 19
JO - International Journal of Environmental Research and Public Health
JF - International Journal of Environmental Research and Public Health
IS - 4
M1 - 2063
ER -